Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level

[1] Wee JT(2010)Is nasopharyngeal cancer really a "Cantonese cancer"? Chin J Cancer 29 517-526

[2] Ha TC(1967)Nasopharyngeal carcinoma. Some observations on the clinical features and technique of examination Pac Med Surg 75 172-174

[3] Loong SL(2012)A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma Radiother Oncol 104 286-293

[4] Qian CN(2015)Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up Eur J Cancer 51 2587-2595

[5] Choa G(2014)Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma Radiat Oncol 9 56-1317

[6] Peng G(2015)Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma Journal of the National Cancer Institute 108 djv291-637

[7] Wang T(1998)Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099 J Clin Oncol 16 1310-4313

[8] Yang K(2003)Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 631-249

[9] Zhang S(2001)Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 4305-1034

[10] Zhang T(2009)Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 242-2500

[1] Wee JT(2010)Is nasopharyngeal cancer really a "Cantonese cancer"? Chin J Cancer 29 517-526

[2] Ha TC(1967)Nasopharyngeal carcinoma. Some observations on the clinical features and technique of examination Pac Med Surg 75 172-174

[3] Loong SL(2012)A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma Radiother Oncol 104 286-293

[4] Qian CN(2015)Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up Eur J Cancer 51 2587-2595

[5] Choa G(2014)Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma Radiat Oncol 9 56-1317

[6] Peng G(2015)Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma Journal of the National Cancer Institute 108 djv291-637

[7] Wang T(1998)Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099 J Clin Oncol 16 1310-4313

[8] Yang K(2003)Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 631-249

[9] Zhang S(2001)Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 4305-1034

[10] Zhang T(2009)Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 242-2500